Moderna shares soar 177% after successful trial of experimental skin cancer jab
The company said a critical late-stage study of an experimental vaccine showed the treatment stopped melanoma from spreading.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.dailymail.co.uk — the content belongs to Daily Mail Money.
